Benjamin L Palleiko

CIK 1366244 · CHIEF EXECUTIVE OFFICER · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

64

Lifetime Open-Market Net

-$5.69M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KALV CHIEF EXECUTIVE OFFICER 0 $27.00 $0 -$5.71M 56 2026-06-11
ORE PHARMACEUTICAL HOLDINGS INC. (ORXE) Delisted SVP & Chief Financial Officer $0 2 2010-01-20
PENWEST PHARMACEUTICALS CO (PPCO) Delisted SVP, Corporate Dev. & CFO 2,500 $16.3K 6 2008-06-18

Recent Filings · Page 2 of 7

64 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-12-09 KALV Mixed +8,331 -$120.4K EDGAR
2025-11-26 KALV Mixed +12,310 -$147.2K EDGAR
2025-11-19 KALV Mixed +4,898 -$64.7K EDGAR
2025-11-13 KALV Mixed +3,792 -$38.4K EDGAR
2025-09-09 KALV Mixed +8,331 -$115.5K EDGAR
2025-08-25 KALV Mixed +12,310 -$144.7K EDGAR
2025-08-19 KALV Mixed +4,953 -$58.1K EDGAR
2025-08-13 KALV Grant (A) $0 EDGAR
2025-07-10 KALV Mixed +54,521 -$517.5K EDGAR
2025-06-10 KALV Mixed +8,456 -$104.0K EDGAR
Showing 1120 of 64
Page 2 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.